HeartSciences annual debt-to-equity ratio
2023
2024
2025
2026
2026
HeartSciences Debt-to-Equity Ratio Growth & History (HSCS)
HeartSciences's debt-to-equity ratio was 1.39 for fiscal 2026.
View full HeartSciences company overviewHeartSciences annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2026 · Jun 30 | 2026-06-30 | 1.39 | — | — |
| 2026 · Apr 30 | 2026-04-30 | 1.39 | −0.72 | −34.23% |
| 2025 | 2025-04-30 | 2.12 | 2.04 | +2786.23% |
| 2024 | 2024-04-30 | 0.07 | −2.38 | −97.01% |
| 2023 | 2023-04-30 | 2.45 | — | — |
HeartSciences quarterly debt-to-equity ratio
Q1.23
Q2.23
Q4.23
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q4.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 · Jun 30 | 2026-06-30 | 1.39 | — | — |
| Q4 2026 · Apr 30 | 2026-04-30 | 1.39 | −0.72 | −34.23% |
| Q3 2026 | 2026-01-31 | 0.13 | −0.13 | −49.44% |
| Q2 2026 | 2025-10-31 | 0.09 | −0.03 | −25.79% |
| Q1 2026 | 2025-07-31 | 0.13 | 0.04 | +49.66% |
| Q4 2025 | 2025-04-30 | 2.12 | 2.04 | +2786.23% |
| Q3 2025 | 2025-01-31 | 0.26 | 0.19 | +298.27% |
| Q2 2025 | 2024-10-31 | 0.12 | — | — |
| Q1 2025 | 2024-07-31 | 0.09 | — | — |
| Q4 2024 | 2024-04-30 | 0.07 | −2.38 | −97.01% |
| Q3 2024 | 2024-01-31 | 0.06 | — | — |
| Q4 2023 | 2023-04-30 | 2.45 | — | — |
| Q2 2023 | 2022-10-31 | 0.54 | — | — |
| Q1 2023 | 2022-07-31 | 0.02 | — | — |
HeartSciences debt-to-equity ratio trends
Between the periods ended 2023-04-30 and 2026-06-30, HeartSciences's debt-to-equity ratio decreased from 2.45 to 1.39, a change of −1.06. The latest reported quarter, Q4 2026 · Jun 30, shows 1.39.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences source filings ↗